1. Home
  2. QLYS vs OPCH Comparison

QLYS vs OPCH Comparison

Compare QLYS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Qualys Inc.

QLYS

Qualys Inc.

HOLD

Current Price

$136.52

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Option Care Health Inc.

OPCH

Option Care Health Inc.

HOLD

Current Price

$21.60

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QLYS
OPCH
Founded
1999
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Nursing Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
QLYS
OPCH
Price
$136.52
$21.60
Analyst Decision
Hold
Buy
Analyst Count
13
7
Target Price
$133.08
$36.57
AVG Volume (30 Days)
828.0K
2.3M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
16.99
3.25
EPS
1.42
0.29
Revenue
$321,607,000.00
$4,998,202,000.00
Revenue This Year
$9.97
$7.21
Revenue Next Year
$7.15
$8.55
P/E Ratio
$94.18
$72.69
Revenue Growth
15.32
16.17
52 Week Low
$74.51
$18.01
52 Week High
$167.86
$36.80

Technical Indicators

Market Signals
Indicator
QLYS
OPCH
Relative Strength Index (RSI) 48.06 50.11
Support Level $136.17 $20.82
Resistance Level $154.54 $22.43
Average True Range (ATR) 8.78 0.60
MACD -3.90 -0.03
Stochastic Oscillator 13.71 49.85

Price Performance

Historical Comparison
QLYS
OPCH

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

About OPCH Option Care Health Inc.

Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.

Share on Social Networks: